Breast development in the first 2 years of life: an association with soy-based infant formulas

Amnon Zung1, Tamar Glaser, Zohar Kerem

  • 1Pediatric Endocrinology Unit, Kaplan Medical Center, Hadassah Medical School, Jerusalem, Israel. amzung2@bezeqint.net

Insights

Soy-based formulas may affect breast tissue development in female infants. Phytoestrogens in soy formula were linked to a preserving effect on breast tissue, particularly in the second year of life.

Area of Science:

  • Pediatric Endocrinology
  • Neonatal Nutrition
  • Endocrinology

Background:

  • Soy-based infant formulas contain phytoestrogens, plant-derived compounds structurally similar to estradiol.
  • Phytoestrogens are known to possess estrogenic activity.
  • The endocrine effects of soy formula on infant development require further investigation.

Purpose of the Study:

  • To evaluate the estrogenic effect of soy-based formulas in female infants.
  • To assess the impact of soy phytoestrogens on breast tissue development in infants.

Main Methods:

  • Cross-sectional study of 694 female infants aged 3 to 24 months.
  • Infants were recruited from general pediatric clinics.
  • Presence of breast buds was used as a marker for endocrine effects of soy phytoestrogens.

Main Results:

  • Breast tissue prevalence was higher in infants fed soy formula compared to breast-fed or dairy-formula-fed infants during the second year of life (22.0% vs 10.3%, P = 0.02).
  • An odds ratio of 2.45 (95% CI 1.11-5.39) indicated increased odds of breast tissue in soy-fed infants.
  • No significant differences in breast bud prevalence were observed during the first year of life.

Conclusions:

  • Phytoestrogens in soy formula may exert a preserving effect on infantile breast tissue.
  • This effect appears to influence the natural decline of breast tissue in early childhood.
  • Soy formula consumption might lead to a slower waning of breast tissue in female infants.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
The Mammary Glands01:12

The Mammary Glands

The female breast is a hemispheric projection of variable size positioned anterior to the pectoralis major and serratus anterior muscles. A fascia layer composed of dense, irregular connective tissue connects it to these muscles.
Each breast features a pigmented projection known as the nipple, through which milk emerges via closely spaced openings of ducts, referred to as lactiferous ducts. Surrounding the nipple is a circular pigmented area of skin named the areola, which appears rough due to...